RE: RE: RE: Two New VaccinesTrue enough except Bioniche already has USpatent(s). The question is whether the way this new vaccine works is sufficientlysimilar enough to warrant a claim of patent infringement, and if that claimwill stand up in the court of law.
However at the end of the day, all thingsbeing equal (like cost, number of vaccinations per cattle, etc.) the one thatworks best will win in the long run. I’m under the impression that we are stillwinning that race and expect to stay ahead with developing the second version.